Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-26-002944
Filing Date
2026-01-09
Accepted
2026-01-09 16:30:01
Documents
2
Period of Report
2026-01-09

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0271418-6k_jyong.htm 6-K 9815
2 UNAUDITED INTERIM CONDENSED CONSOLIDATED BALANCE SHEET AS OF JUNE 30, 2025, AND ea027141801ex99-1_jyong.htm EX-99.1 52694
  Complete submission text file 0001213900-26-002944.txt   63659
Mailing Address 23F-3, NO.95, SEC. 1, XINTAI 5TH RD. XIZHI DIST. NEW TAIPEI CITY Taiwan, Province of China
Business Address 23F-3, NO.95, SEC. 1, XINTAI 5TH RD. XIZHI DIST. NEW TAIPEI CITY Taiwan, Province of China (8862) 27325205
Jyong Biotech Ltd. (Filer) CIK: 0001954488 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9
Type: 6-K | Act: 34 | File No.: 001-42701 | Film No.: 26523382
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)